In a major development, the United States (US)' Health and Human Services Department has stopped a Baltimore, Maryland-based vaccine manufacturer from producing doses of AstraZeneca's COVID-19 vaccines, Livemint.
The development comes days after Emergent BioSolutions had ruined a whopping 15 million doses of the COVID-19 vaccine developed by Johnson & Johnson (J&J) as it accidentally mixed up ingredients from two different vaccines. The mix-up forced the regulator to step in and delay the approval of the output from the facility.
Department has also asked J&J to install a new team to oversee all aspects of the manufacturing of the said facility. Meanwhile, Swedish-British pharmaceutical major AstraZeneca has said that it would work with President Joseph Biden's administration in the US to find an alternative site.
It should be noted that AstraZeneca's COVID-19 vaccine has been developed in collaboration with the University of Oxford. The same is being manufactured in India by Pune based Serum Institute of India (SII) under the name 'Covishield'.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.